MRD / Regn No. : THBC\23-24\05586 Date : 24/06/2026
Patient Name : Uma Venkatesh Age & Gender : 52 Yrs. / Female
Contact No. : 7303727313 UHID :
Ht / Wt / BMI : 167 / 86.3 / 30.94 BP S / BP D : 119 / 76
Allergies : NONE Referred By :
   
Subjective : HTN / T2DM,H/O HYPOS IN PAST - RESOLVED,DID GOOD DIET - LOST WEIGHT BUT SEVERE ACIDITY,EXERCISE LIMITED D/T BACK/KNEE/ CX SPONDYLOSIS,DISCUSSED MEDS VS SURGERY,STOPPED SPICES - ACIDITY RESOLVED - THEN COULD FOLLOW PROPER DIET,WT LOSS 14 KGS ,WALK / PHYSICALLT ACTIVE
Objective : 07-MAY-2026 REPORTS,HBA1C-5.8%,FBS-97/ PPBS-120.5
Plan : RECENTLY STOPPED THE ATURVEDIC MEDS FOR DM - SO WILL CHECK HBA1C > 3 MTHS - IF HBA1C > 5.7% - PLEASE CONTINUE DAPATURN  
S# Generic (Trade) Name Route Dosage Usage Duration
1 DAPATURN 10 MG ORAL 1-0-0 ABF
 12 MTHS
2 VIT D 60K ORAL 1/MTH ANYTIME OF DAY
 TO CONTINUE
3 ZECAL GOLD ORAL 0-1-0 AL / 3 DAYS A WEEK
TO CONTINUE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 24/Jun/2027
Tests Suggested For Next Visit : HBA1C EVERY 3-4 MTHS - IF <=6.5% - CONTINUE DAPATURN AND VISIT IS NOT NEEDED,ONCE EVERY YEAR - JUNE - RFT / LFT / LPID PROFILE / URINE ALBUMIN:CREAT RATIO / RETINA TEST FOR DIABETIC RETINOPATHY
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: